TYPE 1 DIABETES – STEM CELLS CLINICAL TRIAL « The Stem Cell Blog
By solostream on Sep 13, 2009 with Comments 0
Context In 2007, the effects of the autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) in 15 patients with type 1 diabetes mellitus (DM) were reported. Most patients became insulin free with normal levels of …
Excerpt from:
TYPE 1 DIABETES – STEM CELLS CLINICAL TRIAL « The Stem Cell Blog
Filed Under: T1 Info
